Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: Integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e initiative

Rheumatology (United Kingdom)

Volumn 51, Issue 8, 2012, Pages 1416-1425

  Whittle, Samuel L ^a   Colebatch, Alexandra N ^b,c   Buchbinder, Rachelle ^d   Edwards, Christopher J ^b   Adams, Karen ^e   Englbrecht, Matthias ^f   Hazlewood, Glen ^g   Marks, Jonathan L ^b   Radner, Helga ^h   Ramiro, Sofia ⁱ   Richards, Bethan L ^j   Tarner, Ingo H ^k   Aletaha, Daniel ^h   Bombardier, Claire ^g   Landewé, Robert B ^i,l   Müller ladner, Ulf ^k   Bijlsma, Johannes W J ^m   Branco, Jaime C ^n,o   Bykerk, Vivian P ^p,q   Da rocha castelar pinheiro, Geraldo ^r   Catrina, Anca I ^s   Hannonen, Pekka ^t   Kiely, Patrick ^u   Leeb, Burkhard ^v   Lie, Elisabeth ^w   Martinez osuna, Píndaro ^x   Montecucco, Carlomaurizio ^y   østergaard, Mikkel ^z   Westhovens, Rene ^aa   Zochling, Jane ^ab   Van der heijde, Désirée ^ac   more..

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c YEOVIL DISTRICT HOSPITAL   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g UNIVERSITY OF TORONTO   (Canada)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

^j ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^k JUSTUS LIEBIG UNIVERSITY   (Germany)

^l Sittard Geleen Heerlen   (Netherlands)

^m UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁿ UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^o HOSPITAL EGAS MONIZ   (Portugal)

^p MOUNT SINAI HOSPITAL   (Canada)

^q HARVARD UNIVERSITY   (United States)

^r HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^s KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^t Central Hospital   (Finland)

^u ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^v State Hospital Stockerau   (Austria)

^w DIAKONHJEMMET HOSPITAL   (Norway)

^x LIVER RESEARCH UNIT   (Mexico)

^y UNIVERSITY OF PAVIA   (Italy)

^z Mental Health Services CPH   (Denmark)

^aa UNIVERSITY OF LEUVEN   (Belgium)

^ab UNIVERSITY OF TASMANIA   (Australia)

^ac LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Analgesics; Arthritis; Evidence based medicine

Indexed keywords

ANALGESIC AGENT; BENZODIAZEPINE; CAPSAICIN; CODEINE; DEXTROPROPOXYPHENE; GLUCOCORTICOID; METHOTREXATE; MUSCLE RELAXANT AGENT; NEFOPAM; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PENTAZOCINE; TILIDINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; ARTHRITIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COCHRANE LIBRARY; COMORBIDITY; DATA EXTRACTION; DRUG MECHANISM; EMBASE; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; INFLAMMATORY ARTHRITIS; KNEE PAIN; LACTATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; NEUROMODULATION; PAIN; PAIN ASSESSMENT; PATIENT SAFETY; PREGNANCY; PRIORITY JOURNAL; QUALITY CONTROL; RHEUMATOLOGY; SKIN IRRITATION; SYSTEMATIC REVIEW; THERAPY EFFECT;

ALGORITHMS; ANALGESICS; ARTHRITIS; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; FEMALE; HUMANS; PAIN; PAIN MANAGEMENT; PREGNANCY; TREATMENT OUTCOME;

EID: 84865172404     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes032     Document Type: Article

References (62)

1. Bergman MJ. Social and economic impact of inflammatory arthritis. Postgrad Med 2006, Spec No:5-11.
2. Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004;22:1-12.
3. Minnock P, FitzGerald O, Bresnihan B. Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status. Rheumatology 2003;42:995-1000.
4. Heiberg T, Kvien TK. Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum 2002;47:391-7.
5. Machado P, Castrejon I, Katchamart W et al. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2011;70: 15-24.
6. Sidiropoulos PI, Hatemi G, Song IH et al. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology 2008;47: 355-61.
7. Visser K, Katchamart W, Loza E et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009;68: 1086-93.
8. Higgins JP, Green S, Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration 2009.
9. Levels of evidence (March 2009). http://www.cebm.net/index.aspx?o=1025 (28 September 2011, date last accessed).
10. Englbrecht M, Tarner IH, Van Der Heijde D et al. Measuring pain and efficacy of pain treatment in inflammatory arthritis: a systematic literature review. J Rheumatol in press.
11. Hazlewood G, Van Der Heijde D, Bombardier C. Paracetamol for the management of pain in inflammatory arthritis: a systematic literature review. J Rheumatol in press.
12. Tarner IH, Englbrecht M, Schneider M, Van Der Heijde D, Muller-Ladner U. The role of corticosteroids for pain relief in persistent pain of inflammatory arthritis: a systematic literature review. J Rheumatol in press.
13. Kean WF, Rainsford KD, Kean IR. Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use. Inflammopharmacology 2008;16:53-75.
14. van der Goes MC, Jacobs JW, Boers M et al. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice. Ann Rheum Dis 2010;69:1913-9.
15. Richards BL, Whittle SL, Buchbinder R. Antidepressants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 2011;11:CD008920.
16. Emery P, Gibson T. A double-blind study of the simple analgesic nefopam in rheumatoid arthritis. Br J Rheumatol 1986;25:72-6.
17. Swinson DR, Booth J, Baker RD. Nefopam in rheumatoid arthritis. Results of a double-blind placebo controlled study. Clin Rheumatol 1988;7:411-2.
18. Richards BL, Whittle SL, Buchbinder R. Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 2012;1:CD008921.
19. Deal CL, Schnitzer TJ, Lipstein E et al. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther 1991;13:383-95.
20. Arnold LM, Goldenberg DL, Stanford SB et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 2007;56:1336-44.
21. Crofford LJ, Mease PJ, Simpson SL et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008;136: 419-31.
22. Mease PJ, Russell IJ, Arnold LM et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008;35:502-14.
23. Mohler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002;300:2-8.
24. Vince JD, Kremer D. Double-blind trial of diazepam in rheumatoid arthritis. Practitioner 1973;210:264-7.
25. Drewes AM, Bjerregard K, Taagholt SJ, Svendsen L, Nielsen KD. Zopiclone as night medication in rheumatoid arthritis. Scand J Rheumatol 1998;27:180-7.
26. Richards BL, Whittle SL, Buchbinder R. Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 2012;1:CD008922.
27. Goldman A, Hain R, Liben S. Oxford Textbook of Palliative Care for Children. Oxford: Oxford University Press, 2006.
28. Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain, 2010. http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_a_v4_5.pdf (28 September 2011, date last accessed).
29. Whittle Samuel L, Richards Bethan L, Husni E, Buchbinder R. Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev 2011;11: CD003113.
30. Boureau F, Boccard E. Placebo-controlled study of the analgesic efficacy of a combination of paracetamol and codeine in rheumatoid arthritis. Acta Ther 1991;17:123-36.
31. Brunnmuller U, Zeidler H, Alten R, Gromnica Ihle E. [Effective analgesic therapy with tilidine/naloxone for patients with rheumatoid arthritis]. Aktuelle Rheumatologie 2004;29:35-9.
32. Lee EY, Lee EB, Park BJ et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial. Clin Ther 2006;28:2052-60.
33. Boada JN, Boada C, Garcia-Saiz M et al. Net efficacy adjusted for risk (NEAR): a simple procedure for measuring risk:benefit balance. PLoS ONE 2008;3:e3580.
34. Beaver WT. Combination analgesics. Am J Med 1984;77: 38-53.
35. Ramiro S, Radner H, van der Heijde D et al. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev 2011;10:CD008886.
36. Wanders A, van der Heijde D, Landewe R et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005;52:1756-65.
37. Adams K, Bombardier C, van der Heijde D. Safety of on-demand versus continuous use of NSAIDs in patients with inflammatory arthritis: a systematic literature review. J Rheumatol in press.
38. Adams K, Bombardier C, van der Heijde D. Safety of pain therapy during pregnancy and lactation in patients with inflammatory arthritis: a systematic literature review. J Rheumatol in press.
39. Colebatch AN, Marks JL, Edwards CJ. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev 2011;11: CD008872.
40. Carroll GJ, Thomas R, Phatouros CC et al. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 1994;21:51-4.
41. Carson CW, Cannon GW, Egger MJ, Ward JR, Clegg DO. Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate. Semin Arthritis Rheum 1987;16:186-95.
42. Ideguchi H, Ohno S, Ishigatsubo Y. Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis. J Clin Rheumatol 2007;13:73-8.
43. Sanchez G, Castro JS, Snih SA et al. Durability of treatment with methotrexate in Venezuelan patients with rheumatoid arthritis. Rheumatol Int 2007;27:531-6.
44. Swierkot J, Szechinski J. Side effects of methotrexate treatment in patients with rheumatoid arthritis. Adv Clin Exp Med 2008;17:387-94.
45. McKendry RJ, Dale P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 1993;20:1850-6.
46. Fries JF, Singh G, Lenert L, Furst DE. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 1990;33:1611-9.
47. Seideman P, Muller-Suur R. Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis. Ann Rheum Dis 1993;52:613-5.
48. Tohgi H, Konno S, Tamura K, Kimura B, Kawano K. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke 1992;23:1400-3.
49. Pillinger MH, Capodici C, Rosenthal P et al. Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci USA 1998;95:14540-5.
50. Bourre-Tessier J, Haraoui B. Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol 2010;37:1416-21.
51. Radner H, Ramiro S, Buchbinder R et al. Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity. Cochrane Database Syst Rev 2012;1:CD008951.
52. Laine L, Bombardier C, Hawkey CJ et al. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 2002; 123:1006-12.
53. Eisen GM, Goldstein JL, Hanna DB, Rublee DA. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis. Aliment Pharmacol Ther 2005;21:591-8.
54. Marks JL, Colebatch AN, Buchbinder R, Edwards CJ. Pain management for rheumatoid arthritis and cardiovascular or renal co-morbidity. Cochrane Database Syst Rev 2011; 10:CD008952.
55. Cannon CP, Curtis SP, FitzGerald GA et al. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2006;368: 1771-81.
56. Fosbol EL, Kober L, Torp-Pedersen C, Gislason GH. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals. Expert Opin Drug Saf 2010;9:893-903.
57. Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol 2009;103:1227-37.
58. Hermann M. Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs. Curr Rheumatol Rep 2009;11:31-5.
59. Sudano I, Flammer AJ, Periat D et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation 2010;122:1789-96.
60. Crofford LJ. Pain management in fibromyalgia. Curr Opin Rheumatol 2008;20:246-50.
61. Mease PJ, Clauw DJ, Gendreau RM et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:398-409.
62. Russell IJ, Mease PJ, Smith TR et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008;136:432-44.